- Telehealth Visits
- Insurance plan information
Natasha Spottiswoode, MD
Infectious Diseases- Telehealth Visits
- Insurance plan information
Natasha Spottiswoode, MD
Infectious Diseases- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Infectious Disease, American Board of Internal Med/Infectious Disease
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Infectious Diseases, UCSF School of Medicine -GME
Residency
- Internal Medicine, UCSF School of Medicine -GME
Degree
- MD, Columbia University, Vagelos College of Physicians & Surgeons
Academic title
- Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 12 reviews
- May 20, 20265 out of 5 Stars
Excellent care in all regards.
- May 12, 20265 out of 5 Stars
Dr. Sasha showed extreme care in talking to me and explaining my disease to me based on information she had received. She was very attentive with listening and ready my body language completely. I was completely at ease and felt that I was completely taken care of. I could not have wished or prayed for a better doctor or outcome.
- February 3, 20265 out of 5 Stars
It was all excellent on the part of Dr.
- December 11, 20255 out of 5 Stars
All contacts have been very attentive to my condition making changes to my medication based on blood tests.
- November 19, 20255 out of 5 Stars
Dr. Spottiswoode and team are great. Always exceed expectations and always personable.
- September 25, 20255 out of 5 Stars
Excellent consult. Exceeded my expectations. Addressed all necessary issues and encouraged additional dialogue around other care related questions.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.